L

PriceLAVA Therapeutics

LVTX

LAVA Therapeutics NV isa clinical stage immuno-oncology company. It is focused on transforming cancer treatment by developing a platform to selectively induce bispecific antibody utilizing the Gammabody platform for an undisclosed tumor associated antigen for the treatment of cancer. Company's pipeline include's products such as LAVA-1266, LAVA-1427, LAVA-1433, LAVA-1207, PF08046052, JNJ89853413.

Historical stock price chart and annual return over the past years

-91%

4 years

% Total

LVTX
-45%

4 years

Annual Return

LVTX